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Editorial on the Research Topic
Molecular Mechanisms of Immune Complex Pathophysiology
Foreign and modified self-antigens bind to natural IgM to form immune complexes (ICs). This 
facilitates the instructive phase of immunity, which programs immune response to generate class-
switched high affinity antibodies required for IC formation, resulting in pathogen clearance. ICs are 
the first responders of immune challenge. However, accumulation of abnormal IC levels triggers 
disease pathologies such as nephropathies, autoimmunity, cancers, infections, and lung injury. ICs 
are dynamic in their size and composition, present either in systemic circulation or formed locally 
in tissue. In seven reviews in the topic “Molecular Mechanisms of Immune Complex Physiology,” the 
authors describe various pathological and physiological aspects of IC-driven pathologies. Krishna 
and Nadler summarize the consequence of ICs formed by biologics and their role in antigenicity 
to biotherapeutics. Knoppova et al. summarize how galactose-deficient IgA1 bound to IgG or IgA, 
upon forming ICs deposits in glomeruli activate mesangial cells, induce renal injury, and trigger 
cellular proliferation. In membranous nephropathy, autoantibodies to phospholipase A2 receptor 
expressed by podocytes form ICs in situ. Borza discusses how renal injury results from dysregulation 
of the alternate pathway of complement due to loss of heparin sulfate chains. Classical complement 
pathway activation by ICs results in the production of C5a, a potent anaphylatoxin, and membrane 
attack complex (MAC or C5b-9). Sublytic C5b-9 triggers signaling and induces growth factors and 
cytokine secretion in various cell types. C5b-9 in CD4+ T-cells triggers membrane rafts (MRs) clus-
tering, a function attributed to CD28 cosignaling. MRs are membrane organelles rich in signaling 
proteins that play a crucial role in lymphocyte activation. Ward et al. describe in their mini-review 
how ICs participate in the development of acute respiratory distress syndrome and acute lung injury. 
These authors further describe how generation of C5a by ICs upon binding to C5aR1/C5aR2 pro-
motes the appearance of extracellular histones, which are a major component of neutrophil extracel-
lular traps (NETs). In autoimmunity, ribonucleoprotein-containing ICs induce NETosis. It is now 
proposed that the histone citrullination and reactive oxygen species are important for NETosis (1). 
Juvenile idiopathic arthritis (JIA) is characterized by the presence of elevated ICs, and IC deposits 
are observed in patient joints. Moore reviews the presence of ICs in JIA and discusses the role of 
citrullinated peptide antigens such as type II collagen and fibrinogen, which form ICs that contribute 
to disease pathology. Low-affinity Fc receptors bind to ICs and signal by phosphorylating Syk, which 
then utilizes PLC-γ2 downstream. These events have been well studied in B cells. Mutation in gene 
encoding for ZAP-70, a tyrosine kinase protein known to play a key role in T cell receptor (TCR) 
signaling, diverts signaling to Syk, and this shift is associated with the development of autoimmune 
response. Syk signaling is also observed when membrane toll-like receptor (TLR) 4 recognizes LPS. 
The mini-review by Deng et al. summarizes the downstream signaling events associated with Syk 
phosphorylation. These authors further discuss the role of Syk activation in various autoimmune 
modalities and the development of Syk inhibitors for therapeutic use. Signaling from TLRs, which 
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mediates the innate immune response, has gained prominence 
due to its role in nucleic acid sensing. In systemic autoimmunity, 
DNA or RNA-containing ICs (DNA/RNA-ICs) act as vehicles to 
deliver nucleic acids to endosomes, where they are recognized 
by nucleic acid-sensing TLRs (NA-TLRs). In particular, TLR9 
triggers production of type I interferon (IFN) and induces IFN-
stimulated gene expression. Production of IFNs by plasmacytoid 
dendritic cells (pDCs) drives systemic autoimmune responses. In 
pDCs, FcγRIIa delivers DNA/RNA-ICs to the endosomal com-
partment. In a review article on this topic, I summarize the past 
literature on FcRs’ expression in human CD4+ T-cells Chauhan. 
In this review, I propose a model of a possible cross talk between 
FcRs–TLRs–TCR, which in the germinal center could drive the 
differentiation of naïve CD4+ T-cells, resulting in B-cell help 
from the generation of follicular helper T-cells, which contribute 
to autoantibody production. FcγRIIIa signaling in naïve CD4+ 
T-cells leads to the development of proinflammatory effector 
T-cells (2). FcγRIIIa signaling induces expression of NA-TLRs, 
which then localize on the cell surface with FcγRIIIIa (2). FcγRIIIa 
in CD4+ T-cells, upon binding to DNA/RNA-ICs, will deliver 
nucleic acids to endosomal NA-TLRs resulting in a type I IFN 
response. NETs also release DNA, and nucleic acid sensing from 
this DNA release will trigger immune response via TLR9 in CD4+ 
T-cells. FcγRIIIa signaling drives the accumulation of TLR9 as a 
full-length protein on the cell surface, where it recognizes CpG 
ODN 2006. TLR9 on cell surface is critical in discriminating 
modified self-DNA from encapsulated viral-DNA. In summary, 
these review articles highlight recent progress and propose new 
mechanisms to explain how ICs can drive pathology in lung, 
kidney, and autoimmune disorders.
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